Table 1 Baseline clinicopathological features of 72 localized MIBC patients before receiving NAC
Characteristic/feature | Number | Percent |
|---|---|---|
Age: | ||
Mean ± SD | ||
59.2 ± 9 | ||
Median (range) | ||
60.5 (34–87) | ||
Gender | ||
Female | 10 | 13.9 |
Male | 62 | 86.1 |
Residency | ||
Urban | 45 | 62.5 |
Rural | 27 | 37.5 |
Smoking history | ||
No | 21 | 29.2 |
Yes | 51 | 70.8 |
Comorbidities | ||
Yes | 24 | 33.3 |
No | 48 | 66.7 |
Comorbidity type (n = 24) | ||
DM | 7 | 29.2 |
HTN | 5 | 20.8 |
DM and HTN | 4 | 16.6 |
HCV | 7 | 29.2 |
Others | 1 | 4.2 |
Main presenting complaint | ||
Hematuria | 56 | 77.8 |
Necroturia | 6 | 8.3 |
Dysuria, lower abd pain, others | 10 | 13.9 |
Hydronephrosis | ||
Yes | 33 | 45.8 |
No | 39 | 54.2 |
Hydronephrosis laterality (n = 33) | ||
Unilateral | 19 | 57.6 |
Bilateral | 14 | 42.4 |
Hydronephrosis severity (n = 33) | ||
Mild | 13 | 39.4 |
Moderate to marked | 20 | 60.6 |
cT | ||
Tx | 1 | 1.4 |
T2 | 27 | 37.5 |
T3b | 38 | 52.8 |
T4 | 6 | 8.3 |
cN | ||
N0 | 60 | 83.3 |
N1,2 | 12 | 16.7 |
cTNM stage | ||
II | 23 | 31.9 |
IIIA | 46 | 63.9 |
IVA | 2 | 2.8 |
Risk categorya | ||
Low risk | 15 | 20.8 |
High risk | 57 | 79.2 |
Gross cystoscopic findings | ||
Papillary/fungating | 43 | 59.7 |
Ulcerative | 5 | 6.9 |